Vivo Bio Tech peers

·Pharma & HealthChart ›

Companies like Vivo Bio Techlatest year

Vivo Bio TechVIVOBIOT · FY25 · this company
Market cap₹20.2
P/E2.67×
Sales growth—
ROE11.4%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VIVOBIOT₹13.23

Vivo Bio Tech Limited

· Pharma & Health
₹ CroreMcap ₹20.2 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VIVOBIOT
FY25
Peer
Average
Valuation — at last close
P/E2.67×—
P/B0.26×—
EV/EBITDA3.41×—
Market Cap₹20.2 Cr—
Profitability
EBITDA Margin44.56%—
Net Income Margin16.22%—
Return on Common Equity11.42%—
Return on Capital Employed11.20%—
Return on Assets5.48%—
Credit & Quality
Total Debt/Equity0.66×—
Interest Coverage1.57×—
Scale — latest FY
Revenue / Total Income₹46.7 Cr—
Net Income₹7.6 Cr—
Total Assets₹141 Cr—
EPS₹4.95—
Book Value per Share₹51.12—
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.